A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives - Chunhua Zhang; Hua Liang; Yanni Qin; Xiaolan Tan; Xiaoqing Su; Xin Tian; Yumei Nong (PLoS ONE, 2026)